AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. The co-founders of AlphaMol are leading scientists in the area of GPCRs. Many essential molecular mechanisms and biotechnology were invented by the members of AlphaMol.
Cooperation possibilities
- License out our GPCR asset
- Co-development for GPCR drug discovery
- Computational platform for GPCR drug discovery
Some insights
- Accurate platform for GPCR drug discovery
- Biochips for GPCR biological testing in physiological condition
Defeated Google's AlphaFold2 in the Global GPCR-DOCK 2021 contest with 60% higher accuracy.